Device
CFO
CFO is a medical device with 3 clinical trials. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
3
100%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Active(1)
Completed(2)
Detailed Status
Completed2
Not yet recruiting1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
N/A
Trials by Phase
N/A3 (100.0%)
Trials by Status
completed267%
not_yet_recruiting133%
Recent Activity
0 active trials
Showing 3 of 3
completednot_applicable
Combined Effect of Underwater Ultrasound
NCT06753552
completednot_applicable
Customized Foot Orthoses With Orthotic Wedges for Plantar Heel Pain
NCT06319066
not_yet_recruitingnot_applicable
Customized Foot Orthoses on Muscle Activity During Standing and Gait in Plantar Heel Pain
NCT06318910
Clinical Trials (3)
Showing 3 of 3 trials
NCT06753552Not Applicable
Combined Effect of Underwater Ultrasound
NCT06319066Not Applicable
Customized Foot Orthoses With Orthotic Wedges for Plantar Heel Pain
NCT06318910Not Applicable
Customized Foot Orthoses on Muscle Activity During Standing and Gait in Plantar Heel Pain
All 3 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 3